上海爱的发制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
38
NMPA:38
Drug Approvals
Mesalazine Sustained-release Granules
- Product Name
- 美沙拉秦缓释颗粒
- Approval Number
- 国药准字H20217075
- Approval Date
- Mar 11, 2024
NMPA
Mesalazine Sustained-release Granules
- Product Name
- 美沙拉秦缓释颗粒
- Approval Number
- 国药准字H20143164
- Approval Date
- Mar 11, 2024
NMPA
Lansoprazole Enteric-coated Capsules
- Product Name
- 兰索拉唑肠溶胶囊
- Approval Number
- 国药准字H20093108
- Approval Date
- Aug 31, 2023
NMPA
Lansoprazole Enteric Capsules
- Product Name
- 兰索拉唑肠溶胶囊
- Approval Number
- 国药准字H20173008
- Approval Date
- Aug 31, 2023
NMPA
Vincamine Sustained-release Pellets
- Product Name
- 长春胺缓释微丸
- Approval Number
- 国药准字H20073993
- Approval Date
- Jul 15, 2022
NMPA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
No trials found
News
No news found